Company
Legend Biotech ($LEGN)
- Biotech
Description
CAR-T cell therapy company behind ciltacabtagene autoleucel and next-generation cell-therapy programs. Public via $LEGN (NASDAQ). Somerset NJ US HQ.
Related
H. Lee Moffitt Cancer CenterNCI-designated comprehensive cancer center. Significant translational research in immunotherapy, cellular therapy (CAR-T), and AI-driven…
CellaresDevelops and operates automated cell therapy manufacturing technologies and services, helping therapy developers transfer production and…
HexemBioBuilds rejuvenated stem cell therapy aimed at improving aged hematopoietic stem cells and bone marrow transplant outcomes for blood cancer…
Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
Tempus AI ($TEM)AI-driven precision medicine over clinical and molecular data. Public via $TEM (NASDAQ). Chicago HQ.
AsimovBuilds an end-to-end genetic design platform combining synthetic biology and computational tools for biologics, cell therapy, and gene…
Dyno TherapeuticsBuilds high-performance genetic technologies to improve AAV gene delivery for gene therapy, supporting therapeutic developers working on…
March BiosciencesDevelops clinical-stage CAR-T cell therapies, including MB-105, aimed at difficult hematological cancers, with a focus on relapsed or…
Century TherapeuticsDevelops off-the-shelf cell therapy candidates from induced pluripotent stem cells for patients with autoimmune conditions, including type…
Poseida Therapeutics (Roche)Develops cell therapy candidates and related platform technologies, with legacy programs in a biotechnology pipeline for medicines…
Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
Playground GlobalInvests in early-stage technical founders building AI, engineered biology, next-generation computing, automation, and energy transition…